methsuximide 300 MG Oral Capsule [Celontin]

RxNorm concept 207088, branded drug (sbd). Prescribable name: Celontin 300 MG Oral Capsule.

RxCUI: 207088
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/207088 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

methsuximide 47858

Other names

Celontin 300 MG Oral Capsule

Related concepts

methsuximide 300 MG (SCDC, consists of)
methsuximide 300 MG [Celontin] (SBDC, consists of)
Oral Capsule (DF, has dose form)
Celontin (BN, has ingredient)
methsuximide 300 MG Oral Capsule (SCD, tradename of)

Linked data

NDCs

00071052524

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 207088 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/207088 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 207088. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.